Health Economics and Financing and Financing Research Profile

Narrow Drug Formularies and Psychiatric Treatment Failure

A study to examine how often patients with psychiatric illnesses receive prescriptions for drugs to which they have already failed to respond and how this phenomenon is affected by the breadth of the formulary covered by the patient's health insurance.
Contact: Dana Goldman, PhD (Dana_Goldman@and.org) or Geoffrey Joyce, PhD (Geoffrey_Joyce@RAND.org)

Extreme Cost Sharing and the Use of Specialty Drugs

A study using a unique data set to investigate how recent changes in some employer-sponsored plans resulting in high levels of cost sharing for particular specialty drugs are affecting use of these drugs for patients with metastatic cancer and rheumatoid arthritis.
Contact: Dana Goldman, PhD (Dana_Goldman@rand.org) or Geoffrey Joyce, PhD (Geoffrey_Joyce@rand.org)

Implications of Antipsychotic Availability Under Medicaid

A study to examine how state Medicaid formulary policies influence the use of antipsychotic medications, adherence, health spending, and social outcomes.
Contact: Dana Goldman, PhD (Dana_Goldman@rand.org) or Geoffrey Joyce, PhD (Geoffrey_Joyce@rand.org)

Improving Pharmacy Benefit Design

An assessment of the effects of prescription drug cost sharing on patient compliance and outcomes for a diverse set of diseases and drug classes, with particular attention to novel specialty pharmaceuticals and to the Medicare population.
Contact: Dana Goldman, PhD (Dana_Goldman@rand.org) or Geoffrey Joyce, PhD (Geoffrey_Joyce@rand.org)